The receptors that have been identified as capable of binding with endocannabinoids are divided into CB1 receptors, which are mainly concentrated in the central nervous system area, and CB2 receptors, mainly concentrated in the peripheral nervous system.
CB1 receptors are mainly found in neurons, confirming their important role in modulating neurotransmission at specific synapses. The CB1 receptor is directly involved in pleasure circuits, including appetite. The main role of this receptor in the brain is to regulate the release of neurotransmitters such as serotonin, dopamine, and glutamate. The beneficial effects of stimulating CB1 receptors can be achieved by using CBD-based products.
As for the CB2 receptors, it can be said that the main difference lies in their location within the human body. They are mostly found at the peripheral level, particularly in the spleen, tonsils, and immune system cells. CBD binds to the CB1 and CB2 receptors and acts where an imbalance occurs, including in the immune system, helping to restore the initial balance. This is why the indirect action of CBD on the immune system can lead to a "boost in defenses" or, on the contrary, to a partial suppression in cases such as autoimmune diseases: alterations of the immune system that trigger abnormal immune responses to the detriment of the body.
Today's studies hypothesize a possible role of CB2 receptors for support neuropathic pain. In fact, it seems that the stimulation of these receptors induces the release of endogenous opioids such as β-endorphins from keratinocytes, with global "analgesic" effect.
The first studies on the endocannabinoid system
The pioneer of cannabis research, Professor Raphael Mechoulam, stated that without studying cannabis sativa, science would never have discovered the endocannabinoid system.
In 1964, while working at the Weizmann Institute in Israel, Mechoulam was the first—together with colleagues Yechiel Gaoni and Habib Edery—to isolate and analyze delta-9-tetrahydrocannabinol or THC: one of the most well-known active ingredients of cannabis to the public. The researchers observed the positive effects of the molecule on pain, mood, nausea, epilepsy, and muscle spasms, but they could not explain the mechanism behind it.
Then, in 1973 at Johns Hopkins University, a research team discovered that there are receptors in the brain capable of interacting with opioids, such as morphine, which was able to relieve pain. And it was after 15 years that they understood that there were receptors in the brain capable of binding also to cannabinoids produced by cannabis, the cannabinoid receptors. Since 1990, science has officially recognized the endocannabinoid system and began studying it.
Why study the endocannabinoid system?
The identification of cannabinoid receptors and their endogenous lipid ligands has initiated a line of research aimed at exploring the endocannabinoid system and its regulatory functions both in the body of a healthy individual and in the case of a person affected by a pathology.
In the last decade, the endocannabinoid system has been involved in an increasing number of searches on its physiological functions, both in the central and peripheral nervous system and in peripheral organs.
Even more importantly, the modulation of the endocannabinoid system's activity has proven promising in addressing a wide range of diseases and pathological conditions. From mood disorders to diseases such as Parkinson's disease and Huntington's disease, multiple sclerosis, hypertension, or psoriasis.
Endocannabinoid System and Metabolism
The topic of the correlation between cannabis and metabolism is not a recent matter. Starting from the phenomenon of "the munchies," there has always been a certain interest in understanding what the effects and developments of research in this area could be.
The study of the endocannabinoid system is useful for understanding the growing phenomenon of metabolic diseases and theobesity. These are often issues related to an unhealthy lifestyle and diet that over time lead to diseases.
Keeping the endocannabinoid system active and balanced therefore means taking care of yourself in a comprehensive way.